World Wires · Story 50770 · official · 1 Quelle(n)

SCHEDULE 13D: SV Biotech Crossover Opportunities Fund LP discloses a stake in TRex Bio, Inc.

Filed: 2026-10-16 AccNo: 0001829126-26-011242 Size: 51 KB

Im Desk öffnen

Berichterstattung

• SCHEDULE 13D: SV Biotech Crossover Opportunities Fund LP discloses a stake in TRex Bio, Inc. SEC EDGAR: Schedule 13D stakes · Stufe A · Clear Net · 2026-10-16 19:53 UTC

Was diese Seite indexiert